This suggests that the tumor-suppressing role of TGFβ may be at least partially mediated by its ability to stimulate PRG4 expression, whereas a lack of this upregulation mechanism may result in unleashed TGFβ tumor-promoting actions. The gene discussed is PRG4; the disease is neoplasm.